Article de revue
Antibody levels and protection after hepatitis B vaccine: Results of a 30-year follow-up study and response to a booster dose
Based on anti-HBs level ≥10 mIU/mL at 30 years and an 88% booster dose response, the researchers estimate that ≥90% of participants had evidence of protection 30 years later. Booster doses are not needed.
Auteurs
Langues
- Anglais
Année de publication
2016
Journal
J Infect Dis.
Type
Article de revue
Catégories
- Prestation de services
Maladies
- Hépatite B
Pays
- États-Unis
Mots-clés
- Suivi de la couverture
- Introduction de nouveaux vaccins
Régions de l'OMS
- Région des Amériques
